Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 13/20 | 0.55 |
| ▸ | RIPK1 | Q13546 | 5/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23842586 | 1.00 | SLC6A9 (0.55) | SLC6A9RIPK1CHRM4CHRM2CHRM1 | |
| SCHEMBL23830667 | 1.00 | SLC6A9 (0.55) | SLC6A9RIPK1CHRM4CHRM2CHRM1 | |
| SCHEMBL23830661 | 1.00 | SLC6A9 (0.55) | SLC6A9RIPK1CHRM4CHRM2CHRM1 | |
| SCHEMBL23830732 | 0.91 | RIPK1 (0.51) | SLC6A9RIPK1CHRM4 | |
| SCHEMBL23830730 | 0.91 | RIPK1 (0.51) | SLC6A9RIPK1CHRM4 | |
| SCHEMBL23830709 | 0.91 | RIPK1 (0.51) | SLC6A9RIPK1CHRM4 | |
| SCHEMBL23830707 | 0.91 | RIPK1 (0.51) | SLC6A9RIPK1CHRM4 | |
| SCHEMBL23842698 | 0.91 | RIPK1 (0.51) | SLC6A9RIPK1CHRM4 | |
| SCHEMBL23830590 | 0.90 | RIPK1 (0.50) | SLC6A9RIPK1CHRM4 | |
| SCHEMBL23830562 | 0.90 | RIPK1 (0.50) | SLC6A9RIPK1CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | SIRONAX LTD (KY) | 2021-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | RIPK1, RIPK3, RIPK4 | SLC6A9 4181/4885RIPK1 1/4885CHRM4 4394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.